Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-013089
Filing Date
2022-06-17
Accepted
2022-06-17 16:23:54
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5970
  Complete submission text file 0001567619-22-013089.txt   7415
Mailing Address C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address
Bertrand William C JR (Reporting) CIK: 0001291937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 221024187

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations